The Role of Resveratrol in Modulating Neuroinflammation in Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and Cerebral Ischemia - Top-Institutions - MDSpire

The Role of Resveratrol in Modulating Neuroinflammation in Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and Cerebral Ischemia

  • By

  • Haoyu Wang

  • Fei Li

  • Haifan Wang

  • Zenan Tian

  • Hong Fan

  • Zhibin Shi

  • April 21, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Neuropharmacology
    • Neurodegenerative Disease Research

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Neurodegenerative Disease

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Neurodegenerative Diseases
    • Clinical Neurosciences

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neurodegenerative Disease
    • Clinical Research

  • #5

    National Institute of Neurological Disorders and Stroke (NINDS), NIH
    National Institute of Neurological Disorders and Stroke (NINDS), NIH

    Bethesda, MD

    Key Differentiators

    • Neuroscience Research
    • Neuropharmacology
    • Neurodegeneration

Original Source(s)

The Role of Resveratrol in Modulating Neuroinflammation in Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and Cerebral Ischemia

  • by Haoyu Wang, Fei Li, Haifan Wang, Zenan Tian, Hong Fan, Zhibin Shi

  • April 21, 2026

Related Content

Clinical implications of natalizumab Fab-arm exchange in patients with multiple sclerosis

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

A Narrative Review: Do Systemic Drugs Used in the Treatment of Psoriatic Disease Affect Alzheimer’s Disease?